Wu et al. [73] showed that TNFRSF13C downregulation and overexpression of CXCL12 contribute to the confirmation of AD diagnosis; the number of β-cells can also play an important role in the etiology of the disease. The gene discussed is CXCL12; the disease is Alzheimer disease.